Canada markets closed

Sun Pharmaceutical Industries Limited (SUNPHARMA.BO)

BSE - BSE Real Time Price. Currency in INR
Add to watchlist
1,522.40+7.15 (+0.47%)
At close: 03:54PM IST
Currency in INR

Valuation Measures4

Market Cap (intraday) 3.65T
Enterprise Value 3.48T
Trailing P/E 38.16
Forward P/E 26.67
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)7.65
Price/Book (mrq)5.74
Enterprise Value/Revenue 7.29
Enterprise Value/EBITDA 25.08

Trading Information

Stock Price History

Beta (5Y Monthly) 0.49
52-Week Change 347.02%
S&P500 52-Week Change 322.55%
52 Week High 31,638.70
52 Week Low 31,028.35
50-Day Moving Average 31,503.98
200-Day Moving Average 31,370.58

Share Statistics

Avg Vol (3 month) 389.21k
Avg Vol (10 day) 3114.64k
Shares Outstanding 52.4B
Implied Shares Outstanding 62.4B
Float 81.06B
% Held by Insiders 154.69%
% Held by Institutions 127.79%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 413.5
Forward Annual Dividend Yield 40.89%
Trailing Annual Dividend Rate 313.50
Trailing Annual Dividend Yield 30.89%
5 Year Average Dividend Yield 40.94
Payout Ratio 431.33%
Dividend Date 3N/A
Ex-Dividend Date 4Jul 12, 2024
Last Split Factor 22:1
Last Split Date 3Jul 29, 2013

Financial Highlights

Fiscal Year

Fiscal Year Ends Mar 31, 2024
Most Recent Quarter (mrq)Mar 31, 2024

Profitability

Profit Margin 19.75%
Operating Margin (ttm)20.37%

Management Effectiveness

Return on Assets (ttm)7.84%
Return on Equity (ttm)15.20%

Income Statement

Revenue (ttm)484.97B
Revenue Per Share (ttm)202.06
Quarterly Revenue Growth (yoy)9.60%
Gross Profit (ttm)N/A
EBITDA 129.87B
Net Income Avi to Common (ttm)95.76B
Diluted EPS (ttm)39.89
Quarterly Earnings Growth (yoy)33.80%

Balance Sheet

Total Cash (mrq)191.05B
Total Cash Per Share (mrq)79.89
Total Debt (mrq)32.74B
Total Debt/Equity (mrq)4.88%
Current Ratio (mrq)2.56
Book Value Per Share (mrq)266.22

Cash Flow Statement

Operating Cash Flow (ttm)121.35B
Levered Free Cash Flow (ttm)75.42B